Goldman Sachs analyst Matthew Sykes lowered the firm’s price target on Danaher (DHR) to $240 from $260 but keeps a Buy rating ...

CNN senior political analyst Scott Jennings and New York Times journalist Lulu Garcia-Navarro discuss the market’s volatility ...

The retention packages for Chief Executive Officer David Solomon and President John Waldron give the latter more reason to ...

From analyst to partner, seven Goldman employees shared a look at how the bank's internal ChatGPT-like tool is making their ...

Tesla (NASDAQ:TSLA) kicked off 2025 with sky-high expectations, but reality had other plans. When Elon Musk called this year ...

Target (TGT) shares slipped as much as 1.5% in pre-market trading Wednesday after Goldman Sachs downgraded the stock, citing ...

Goldman Sachs lowered the firm’s price target on Pentair (PNR) to $95 from $104 and keeps a Neutral rating on the shares. The company reported strong Q1 results with top and bottom line results ...

Goldman Sachs analyst Lizzie Dove downgraded the outlook for U.S. Lodging C-Corps and Timeshares due to weaker consumer ...

Goldman Sachs analyst James Quigley maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK825.00.

The latest price target for Goldman Sachs Group (NYSE:GS) was reported by RBC Capital on April 15, 2025. The analyst firm set a price target for $560.00 expecting GS to rise to within 12 months (a ...

Photo shows Neha Bhat, a graduating senior at Rutgers Business School-New Brunswick. Bhat will begin working at Goldman Sachs after graduation.